Formulation design of a novel fast-disintegrating tablet

被引:107
作者
Mizumoto, T
Masuda, Y
Yamamoto, T
Yonemochi, E
Terada, K
机构
[1] Astellas Pharma Inc, Pharmaceut Res & Dev Labs, Shizuoka 4250072, Japan
[2] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan
关键词
fast-disintegrating; saccharide; compressibility; amorphous; conditioning process;
D O I
10.1016/j.ijpharm.2005.09.009
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
As our society is becoming increasingly aged, the development of an appropriate dosage form for the elderly patients is mostly e desirable. A novel fast-disintegrating tablet was investigated in this study as a user-friendly dosage form for the aged. Advantages of this formulation have sufficient hardness and can be manufactured by commonly used equipment. Saccharides can be divided into high- and low-compressibility categories, and an appropriate material for fast-disintegrating tablets was created by taking advantage of this fact. To improve the compressibility of low-compressibility saccharides, particle modification was conducted by coating and granulating a low-compressibility saccharide with a high one to enable the production of a fast-disintegarating tablet. Another discovery was that the high-compressibility saccharide used as a binder solution was present in an amorphous state after the granulation process. The crystal change from amorphous to crystal state intentionally by a conditioning process after compression enabled to increase tablet hardness by strengthening adhesion between particles. The conditioning process made it possible to achieve sufficient hardness while maintaining the fast disintegration time. As a result. this fast-disintegrating tablet that can be manufactured by commonly used equipment, can be used for the dosing of a wide range drugs. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 11 条
[1]
CHANG RK, 2000, PHARM TECHNOL, V24, P52
[2]
Cousin G, 1995, US Patent, Patent No. 5464632
[3]
DAIRAKU M, 2003, JPI J, V41, P836
[4]
HANAWA T, 1995, CHEM PHARM BULL, V43, P284
[5]
HONDA Y, 1998, JPN J HOSP PHARM, V24, P533
[6]
ITOU A, 1994, JPN J HOSP PHARM, V20, P41
[7]
KATOU S, 1993, PHARM TECH JPN, V9, P713
[8]
Drug-delivery products and the Zydis fast-dissolving dosage form [J].
Seager, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (04) :375-382
[9]
Sugihara M, 1986, JPN J HOSP PHARM TEC, V12, P322
[10]
TUSHIMA Y, 2001, J JPN SOC PHARM MACH, V10, P5